Cortisol secretion and Alzheimer's disease progression

Biological Psychiatry

Volumn 42, Issue 11, 1997, Pages 1030-1038

  Weiner, Myron F ^a,b   Vobach, Stephen ^a   Olsson, Kirsten ^a   Svetlik, Doris ^a   Risser, Richard C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; cortisol; hypophyseal pituitary adrenal axis

Indexed keywords

HYDROCORTISONE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; SURVIVAL;

AGED; AGING; ALZHEIMER DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEUROBEHAVIORAL MANIFESTATIONS; PSYCHIATRIC STATUS RATING SCALES; SURVIVAL;

EID: 0030661790     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00165-0     Document Type: Article

References (51)

1. Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Novacenko H, Ostrow LC. Cortisol secretion in relation to age in major depression. Psychosom Med. 43:1981;235-242.
2. Balldin J, Gottfries C-G, Karlsson I, Lindstet G, Langstrom G, Walinder J. Dexamethasone suppression test and serum prolactin in dementia disorders. Br J Psychiatry. 143:1983;277-281.
3. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haslett RF, et al. A specific test for the diagnosis of melancholia. Arch Gen Psychiatry. 38:1981;15-22.
4. Davis KL, Davis BM, Greenwald BS, Mohs RC, Mathé AA, Johns CA, et al. Cortisol and Alzheimer's disease I. Basal studies . Am J Psychiatry. 143:1986;300-305.
5. de Leon MJ, McRae T, Tsai JR, George AJ, Marcus DL, Freedman M, et al. Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet. ii:1988;391-392.
6. Diggle PJ, Liang K, Zeger SL. Analysis of Longitudinal Data. 1994;Oxford University Press, New York.
7. Ferrier IN, Pascual J, Charlton BG, Wright C, Leake A, Griffiths HW, et al. Cortisol, ACTH, and dexamethasone concentrations in a psychogeriatric population. Biol Psychiatry. 23:1988;252-260.
8. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State A practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res. 12:1975;189-198.
9. Fogel B, Satel S, Levy S. Occurrence of high concentrations of postdexamethasone cortisol in elderly psychiatric inpatients. Psychiatry Res. 15:1985;85-92.
10. Greenspan SL, Rowe JW, Maitland LA, McAloon-Dyke M, Elahi D. The pituitary-adrenal glucocorticoid response is altered by gender and disease. J Gerontol. 48:1993;M72-M77.
11. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia A cause of mental deterioration in the elderly . Lancet. ii:1974;207-210.
12. Halbreich U, Zumoff B, Kream J, Fukushima DF. The mean 1-4 PM plasma cortisol concentration as a diagnostic test for hypercortisolism. J Clin Endocrinol Metab. 54:1982;1262-1264.
13. Halbreich U, Asnis GM, Zumoff B, Nathan RS, Shindledecker R. Effect of age and sex on cortisol secretion in depressives and normals. Psychiatry Res. 13:1984;221-229.
14. Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS. Cortisol secretion in endogenous depression I. Basal plasma levels . Arch Gen Psychiatry. 42:1985;904-908.
15. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
16. Hollander E, Mohs RC, Davis KL. Cholinergic approaches to the treatment of Alzheimer's disease. Br Med Bull. 42:1986;97-100.
17. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 140:1982;566-572.
18. Landfield PW. An endocrine hypothesis of brain aging and studies on brain-endocrine correlations and monosynaptic neurophysiology during aging. Finch CE. Parkinson's Disease Vol. 2. Aging and Neuroendocrine Relationships . 1978;179-199 Plenum, New York.
19. Lawlor BA, Tsuboyama G, Ryan T, Mohs RC, Davis BM, Davidson M, et al. Agitation and postdexamethasone cortisol levels in Alzheimer's disease. Am J Psychiatry. 149:1992;546-548.
20. Lawlor BA, Mohs RC, Losonczy M, Ryan TM, Guo L, Davis KL, et al. Hypercortisolism and brain ventricular size in normal aging and Alzheimer's disease. Am J Geriatr Psychiatry. 2:1994;251-252.
21. Lewis DA, Pfohl B, Schlecte J, Coryell W. Influence of age on the cortisol response to dexamethasone. Psychiatry Res. 13:1984;213-220.
22. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NP, Meany MJ. Basal cortisol levels and cognitive deficits in human aging. J Neurosci. 14:1994;2893-2903.
23. Maeda K, Tanimoto K, Terada T, Shintani T, Kakigi T. Elevated urinary free cortisol in patients with dementia. Neurobiol Aging. 12:1991;161-163.
24. Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R, et al. Memory impairment in Cushing's disease. Acta Neurol Scand. 87:1993;52-55.
25. McEwen BE. Re-examination of the glucocorticoid hypothesis of stress and aging. Prog Brain Res. 93:1992;365-383.
26. McEwen BE, Weiss JM, Schwartz LS. Selective retentionof corticosterone by limbic structures in rate brain. Nature. 220:1968;911-912.
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease Report of the NINCDS-ADRDA Work Groups under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease . Neurology. 34:1984;939-944.
28. Meaney M, Aitken D, Bhatnagar S, Van Berkel C, Sapolsky R. Postnatal handling attenuates neuroendocrine, anatomical and cognitive impairments related to the aged hippocampus. Science. 238:1988;766-768.
29. Meneilly GS, Minaker KL, Young JB, Landsberg L, Rowe JWI. Counterregulatory responses to insulin-induced glucose reduction in the elderly. J Clin Endocrinol Metab. 61:1985;178-182.
30. Miller AH, Sastry G, Speranza AJ Jr, Lawlor BA, Mohs RC, Ryan TM, et al. Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease. Am J Psychiatry. 151:1994;267-270.
31. Näsman B, Olsson T, Seckl JR, Eriksson S, Viitanen M, Bucht G, et al. Abnormalities in adrenal androgens, but not of glucocorticoids, in early Alzheimer's disease. Psychoneuroendrocrinology. 20:1995;83-94.
32. Näsman B, Olsson T, Fagerlund M, Eriksson S, Viitanen M, Carlström K. Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol Psychiatry. 39:1996;311-318.
33. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci. 14:1994;2047-2053.
34. O'Brien JT, Schweitzer I, Ames D, Tuckwell V, Mastwyck M. HPA axis function in depression and dementia A review . Biol Psychiatry. 36:1994;389-394.
35. Oxenkrug GF, Pomara N, McIntyre IM, Branconnier RJ, Stanley M, Gershon S. Aging and cortisol resistance to suppression by dexamethasone A positive correlation . Psychiatry Res. 10:1983;125-130.
36. Peskind ER, Raskind MA, Wingerson D, Pascualy M, Thal LJ, Dobie DJ, et al. Hypothalamic-pituitary-adrenocortical axis responses to physostigmine Effects of Alzheimer's disease and gender . Biol Psychiatry. 40:1996;61-68.
37. Raadsheer FC, van Heerikhuize JJ, Lucasen PJ, Hoogendijk WJG, Tilders FJH, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry. 152:1995;1372-1376.
38. Raskind MA, Peskind ER, Wilkinson CW. Hypothalamic-pituitary-adrenal axis regulation and human aging. Ann NY Acad Sci. 746:1994;327-335.
39. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 141:1984;1356-1364.
40. Sapolsky RM, Altmann J. Increase of hypercortisolism and dexamethasone resistance increases with age among wild baboons. Biol Psychiatry. 30:1991;1008-1016.
41. Sapolsky RM, McEwen BS. Stress, glucocorticoids and their role in degenerative changes in the aging hippocampus. Crook T, Bartus R, Ferris S, et al. Treatment Development Strategies for Alzheimer's Disease. 1986;151-172 Mark Powley Associates, New Canaan, CT.
42. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci. 10:1990;2897-2902.
43. Seeman TE, Robbins RJ. Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev. 15:1994;233-260.
44. Sherman B, Wysham C, Pfohl B. Age-related changes in 16 circadian rhythm of plasma cortisol in man. J Clin Endocrinol Metab. 61:1985;439-443.
45. Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry. 32:1992;756-765.
46. Swanwick GRJ, Coen RF, Walsh B, Coakley D, Lawlor BA. The predictive value of hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease. Biol Psychiatry. 39:1996;976-978.
47. Tourigny-Rivard M-F, Raskind M, Rivard D. The dexamethasone suppression test in an elderly population. Biol Psychiatry. 16:1981;177-184.
48. Weiner MF. Age and cortisol suppression by dexamethasone. J Psychiatr Res. 23:1989;163-168.
49. Weiner MF, Davis BM, Mohs RC, Davis KL. Influence of age and relative weight on cortisol suppression in normal subjects. Am J Psychiatry. 144:1987;646-649.
50. Weiner MF, Bruhn M, Svetlik DS, Tintner R, Hom J. Experiences with depression in a dementia clinic. J Clin Psychiatry. 52:1991;234-238.
51. Weiner MF, Vobach S, Svetlik D, Risser RC. Cortisol secretion and Alzheimer's disease progression A preliminary report . Biol Psychiatry. 34:1993;158-161.